Altimmune Inc. (ALT)
ALT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.43
-5.08% on the day
Market cap
$472.7M
Small cap
Revenue · 2025
$41K
+105.0% on 2024
Net income · 2025
-$88.1M
-214861.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ALT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001326190 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $41K |
| Net income | -$88.1M |
| Operating income | -$94.5M |
| Net margin | -214861.0% |
| Operating margin | -230461.0% |
| Revenue growth | +105.0% |
| Cash | $43.8M |
| Total assets | $279.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 11528.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-04-24 |
| Latest annual report | 10-K | 2026-03-06 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-09-29 |
| Latest proxy | DEF 14A | 2026-03-17 |
Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -11.7% |
| 1 month | -27.2% |
| 3 months | -17.5% |
| Year to date | -34.9% |
| 1 year | -41.3% |
| From 52-week high | -62.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OCS | Oculis Holding AG | $7.62 | -3.30% | $469.3M |
| EVO | Evotec SE | $1.34 | -1.82% | $478.5M |
| CBIO | Crescent Biopharma Inc. | $12.91 | -10.72% | $479.5M |
| MNPR | Monopar Therapeutics Inc. | $72.08 | -6.45% | $483.8M |
| BLSM | BlossomHill Therapeutics Inc. | $15.48 | -10.37% | $492.0M |
| EOLS | Evolus Inc. | $7.51 | -3.10% | $496.0M |
| ARVN | Arvinas Inc. | $6.84 | -8.19% | $447.2M |
| RZLT | Rezolute Inc. Common Stock (NV) | $4.61 | -5.34% | $445.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier